<DOC>
	<DOC>NCT02899455</DOC>
	<brief_summary>A phase 3 study to evaluate efficacy and safety of Co-administered HGP0904, HGP0608 and HGP0816 in Patients with Hypertension and Dyslipidemia</brief_summary>
	<brief_title>Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia</brief_title>
	<detailed_description>This study is designed as a multi-center, double-blinded, randomized, phase 3 clinical trial to evaluate the efficacy and safety of Co-administered HGP0904, HGP0608 and HGP0816 in Patients with Hypertension and Dyslipidemia</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<criteria>1. 19 ≤ age ≤ 75 2. at Visit 1 1) BP: sitDBP ≥ 90mmHg 2) Cholesterol : LDLC ≤ 250mg/dL, TG &lt; 400mg/dL 3. at Visit 2 : after TLC (after 4weeks) 1) BP: 80 mmHg ≤ sitDBP &lt; 110mmHg 2) Cholesterol : following risk category (Cardiovascular Risk category) A : CHD risk factor 0 1, 160mg/dL ≤ LDLC ≤ 250mg/dL B①: CHD risk factor≥2 and 10 year risk &lt;10%, 160mg/dL ≤ LDLC ≤ 250mg/dL B②: CHD risk factor≥2 and 10 year risk =1020%, 130mg/dL ≤ LDLC ≤ 250mg/dL C : CHD/CHD risk equivalents* or 10 year risk&gt;20 ,100mg/dL ≤ LDLC ≤ 250mg/dL 3) TG &lt; 400mg/dL 4. Patients understood the contents and purpose of this trial and signed informed consent form 1. At Visit 1, BP difference SBP ≥20mmHg or DBP ≥10mmHg 2. Tolerance or Hypersensitivity Angiotensin II receptor blocker or HMGCoA. reductase inhibitor, Calcium channel blocker(dihydropyridine) or Multidrug allergy 3. Fibromyalgia, myopathy, rhabdomyolysis or acute myopathy or medical history of adverse effect to statin 4. CPK normal range ≥ 3times 5. Uncontrolled primary hypothyroidism(TSH normal range ≥ 2 times) 6. Renal disease or suspected renal disease (Scr ≥ 2mg/dL, AST or ALT≥2 times) 7. Active gout or hyperuricemia(at Visit 1, uric acid &gt; 9mg/dL) 8. IDDM or uncontrolled diabetes mellitus (HbA1c&gt;9%) 9. ventricular arrhythmia 10. medical history severe cerebrovascular disease within 6 months (cerebral infarction, cerebral hemorrhage), hypertension encephalopathy, transient cerebral ischemic attack(TIA) severe heart disease(heart failure of NYHA class IIIIV), valvular disease of heart or myocardial infarction and unstable angina angioplasty or coronary artery bypass graft(CABG) surgery within 6months</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Hyperlipidemia</keyword>
</DOC>